The Latest in Pain

FDA OKs first orally disintegrating agent for rapid migraine relief

February 28, 2020

FDA approves first IV migraine prevention drug

February 24, 2020

CDC: Opioid prescribing and use rates down since 2010

January 31, 2020

Cannabis for sleep: Short-term benefit, long-term disruption?

January 26, 2020

FDA advisers set high bar for new opioids

January 21, 2020

FDA committee rejects oxycodegol, new opioid designed for less abuse

January 14, 2020

FDA okays ubrogepant for acute migraine treatment

December 23, 2019

In addiction, abusive partners can wreak havoc

December 9, 2019

Addiction specialists: Cannabis policies should go up in smoke

December 9, 2019

Chronic pain more common in women with ADHD or ASD

November 21, 2019

Depression linked to persistent opioid use after hysterectomy

November 20, 2019

Opioids, benzodiazepines carry greater risk of COPD-related hospitalization

October 25, 2019

Pain

Clinical interventions for global drug use need updating

October 23, 2019

Drug crisis continues to evolve beyond opioids

October 22, 2019

Migraines linked to higher risk of dementia

September 6, 2019